导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 9.24% | 334/1050 |
| 近一周 | -2.22% | 751/1104 |
| 近一月 | -6.71% | 935/1103 |
| 近一季 | -14.44% | 850/1092 |
| 近半年 | 7.65% | 294/1070 |
| 近一年 | 17.11% | 285/1018 |
| 近两年 | 96.92% | 219/926 |
| 近三年 | 75.50% | 143/834 |
| 成立以来 | 78.34% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.27% 732/1070 |
39.64% 262/1101 |
- - |
- - |
| 2025 | 59.18% 117/1065 |
9.53% 160/1014 |
-2.84% 883/1038 |
49.11% 90/1050 |
0.32% 436/1065 |
| 2024 | 7.84% 336/1011 |
-0.14% 325/960 |
3.31% 148/983 |
7.60% 794/991 |
-2.86% 522/1011 |
| 2023 | -9.65% 317/952 |
0.70% 594/880 |
2.62% 76/895 |
-7.08% 435/915 |
-5.90% 598/952 |
| 2022 | -37.51% 719/867 |
-20.84% 563/773 |
6.70% 425/806 |
-19.96% 750/845 |
-7.58% 726/867 |
| 2021 | -1.60% 374/740 |
-5.12% 345/580 |
7.82% 412/659 |
-2.08% 257/704 |
-1.77% 506/740 |
| 2020 | - - |
- - |
36.76% 51/466 |
17.61% 88/517 |
18.14% 150/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 摩根慧选成长股票C VS. 东吴新产业精选股票A(580008) |